The Truth About Perimenopause and Mental Health

If your mood has shifted in ways you cannot explain, if anxiety has crept in where there was none, or if you simply do not feel like yourself anymore, you are not imagining it and you are not alone. The connection between perimenopause and mental health is real, well documented, and taken seriously by the researchers and clinicians who study it. For a long time these symptoms were brushed aside as stress, or a rough patch, or just life. The evidence tells a different and far more validating story.

This is a longer and more detailed piece than most on this site, because the subject deserves it. We will walk through what the research shows: why this stage of life raises the risk of depression and anxiety, what is happening in the brain to cause it, who is most vulnerable, and, most importantly, what helps. Wherever possible the sources are linked, so you can read them for yourself.

The most authoritative guidance on this comes from a 2018 expert panel convened by the North American Menopause Society and the National Network of Depression Centers. Canadian psychiatry was represented on the panel by Dr. Claudio Soares of Queen’s University. After systematically reviewing the published evidence, the panel described perimenopause as a window of vulnerability for both depressive symptoms and full major depressive episodes. That phrasing matters. It means the hormonal transition does not merely coincide with low mood. It actively raises the risk.

Canadian clinical guidance points the same way. The Society of Obstetricians and Gynaecologists of Canada notes on its menopause hub that the transition brings increased vulnerability to new and worsening mood disorders, and that pre-existing mental health concerns can be exacerbated, pointing to a two- to fourfold rise in the risk of major depression during these years.

There is an important nuance the 2018 guideline is careful to make. For most women, perimenopausal depression is not the first depression they have ever had. The panel found that the majority of midlife women who experience a major depressive episode during perimenopause have lived through an earlier one at some point. For others, it truly is the first time. This matters because of how easily it gets misread in the exam room. If you have never been depressed before, a doctor may wave off a sudden episode at forty-seven as ordinary stress, missing that perimenopause has opened the door. If you have been depressed before, that same doctor may treat the episode purely as a relapse of an old condition, missing that this one is being driven by a hormonal shift that may call for a different approach. Either way the hormonal piece slips through the cracks, and that is exactly what leaves women undertreated.

The hormonal transition of perimenopause does not just coincide with low mood. It raises the risk. Knowing that changes everything about how it should be treated.

Perimenopausal mental health symptoms do not always look like a textbook case of depression. Sometimes they do, but often they arrive in quieter, easier-to-dismiss forms: a low and flat mood, a much shorter fuse, a sense of dread, tearfulness that catches you off guard, or anxiety with no obvious cause. The American College of Obstetricians and Gynecologists points out that these mood symptoms can appear with no clear pattern and unconnected to your menstrual cycle, sometimes lingering for years.

Anxiety deserves its own mention, because it is one of the most common and least expected symptoms. The Study of Women’s Health Across the Nation, a major long-term study tracking women through midlife, found that women who were not especially anxious before perimenopause became significantly more likely to experience high anxiety during it, and that this held true even after accounting for stressful life events, financial strain and hot flashes. The transition itself appears to turn up the dial, not just the circumstances around it.

Part of what makes all of this so hard to spot is that the emotional symptoms tangle with the physical ones. The 2018 guideline noted that menopause symptoms like hot flashes and broken sleep complicate, overlap with, and can worsen the picture of depression. That overlap is one of the main reasons these mood changes are so often missed or filed away as ordinary stress.

None of this is in your head, or rather, it is in your head in the most literal, biochemical sense. Estrogen is not only a reproductive hormone. It helps regulate the very brain chemicals that govern mood. Johns Hopkins Medicine explains that as estrogen levels fall, serotonin drops while the stress hormone cortisol rises, a combination that leaves many women feeling low, anxious and on edge for no clear reason.

One of these brain changes has been measured directly. At the Centre for Addiction and Mental Health in Toronto, a team led by Dr. Jeffrey Meyer used brain imaging to show that levels of an enzyme called monoamine oxidase-A, which breaks down mood-regulating chemicals like serotonin, were about a third higher during perimenopause than in younger women, and the women with the highest levels were the ones crying most easily. The same team notes that first-time clinical depression in perimenopause reaches roughly 16 to 17 percent, well above what you would expect at most other points in adult life. It is a rare, concrete look at a physical change in the brain that matches how women in this stage feel.

It is not only how much hormone is present, but how sensitive a given brain is to the change, which helps explain why two women with similar hormone levels can have completely different experiences. A National Institute of Mental Health experiment showed this with unusual clarity. Women with a history of perimenopausal depression were given estradiol and felt well, then were switched to a placebo without being told. Those taken off the hormone saw their depressive symptoms return, while those who stayed on it did not. The change in hormone, not anything happening in their lives, was driving the mood.

Perimenopause raises the odds of mental health symptoms for everyone moving through it, but some women are considerably more vulnerable than others. Knowing where you stand can help you and your doctor stay a step ahead.

The single strongest predictor is a previous episode of depression, which is why the 2018 guideline places so much weight on it. A history of PMDD or postpartum depression points to a brain that is sensitive to hormonal shifts, the same sensitivity that can flare during perimenopause. And the sleep deprivation that comes with relentless night sweats is itself a powerful driver of low mood, which is part of why treating the physical symptoms so often lifts the emotional ones.

For some women, the mental health toll of this transition reaches beyond low mood into something more serious, including thoughts of self-harm or suicide. This is hard to talk about, but it matters, because awareness can save a life.

A 2025 systematic review of the research found that most of the studies it examined reported a link between the menopause transition and increased suicidality, with several pointing specifically to the perimenopausal years. The authors were careful to say the evidence is associational and limited by how the studies were designed, so this is not a settled certainty. It is a real and repeated signal that deserves attention. In one UK menopause clinic, around one in six women reported thoughts of self-harm or suicide in the two weeks before their first appointment.

If you recognize yourself in any of this, please treat it as a reason to reach out today, to your doctor, someone you trust, or a crisis line, rather than something to ride out alone. These feelings are a symptom, they are treatable, and they are not a verdict on you or your life. The helpline at the top of this page is there for exactly this, at any hour of any day.

Here is the most important part. Perimenopausal depression and anxiety respond well to treatment. There is no single answer that fits everyone, but there is a real menu of options with evidence behind them. Because these symptoms are so often hormonal at their root, the most sensible place to begin is often the hormonal change driving them.

Hormone therapy is a legitimate first-line option. Because falling and fluctuating estrogen is part of what drives these mood changes, restoring some of it can treat the cause rather than only the symptoms. A 2018 clinical trial found that transdermal estradiol with micronized progesterone prevented depressive symptoms in perimenopausal and early postmenopausal women, and the benefit was clearest for women earlier in the transition, which is exactly the window this article is about. In Canada, CMAJ describes hormone therapy as a first-line option for menopausal symptoms, with mood often improving alongside. Leading menopause experts are increasingly direct about this. In Australian clinical guidance, psychiatrist Jayashri Kulkarni advises clinicians to consider hormone therapy rather than antidepressants first when the depression is likely hormonal and there is no history of mental illness, adding antidepressants later only if they are needed. One thing worth saying plainly: estrogen is not formally licensed as a depression drug, and the trial evidence is strongest for perimenopausal women who also have hot flashes. But that is a fact about regulatory labelling, not a verdict on whether it helps the women living through this.

Antidepressants have a real role too. The 2018 guideline confirms that proven depression treatments, antidepressants and psychotherapy, work for perimenopausal depression much as they do at other points in life. For some women they are the right first step, particularly where there is a strong personal history of depression, where symptoms are severe, or where hormone therapy is not wanted or not suitable. If thoughts of self-harm are present, experts are clear that antidepressants should be started promptly rather than waited on. The point is not that antidepressants are wrong. It is that they are one tool among several, rather than the automatic default for a problem that is so often hormonal at its root.

Cognitive behavioural therapy is worth asking about. Beyond medication, structured talk therapy has solid evidence for easing both the mood and the anxiety of this stage, including approaches developed specifically for the menopause transition. CBT works by helping you catch and reframe the spiraling, worst-case thoughts that low mood and anxiety tend to amplify, and by giving you concrete ways to settle the body’s stress response in the moment. Its benefits can also outlast the treatment, since the coping skills you build stay with you after the final session, where a medication works only for as long as you take it.

Tend to the physical symptoms, and be kind to yourself about the rest. Some of the usual advice here, protect your sleep, move your body, watch the alcohol, is easier said than done, and being told to “just sleep more” while hot flashes wake you at three in the morning is its own particular frustration. So here is the version that respects your intelligence. Poor sleep and untreated hot flashes feed low mood directly, which is why getting those physical symptoms under control, often with the treatments above, tends to lift mood as a real side benefit. Movement supports brain chemistry even in modest amounts, with no marathon required. And while you do not have to give up the glass of wine you look forward to, it helps to know that alcohol fragments the already-fragile sleep of this stage and can sharpen next-day anxiety, so noticing that link tends to be more useful than any guilt about it.

Your hormones changed. The depression came with them. That is not weakness, and it is not permanent. It is biology, and biology can be treated.

One of the most frustrating failures in this area is how often these symptoms are missed. Because the emotional and physical symptoms overlap, and because women in midlife are so frequently told they are simply stressed or tired, perimenopausal depression is under-recognized and under-treated. Researchers reviewing the evidence have repeatedly called for mental health to be built into routine menopause care, rather than handled as an afterthought. Some clinicians have shown what that looks like in practice. In Australia, psychiatrist Jayashri Kulkarni developed a screening tool called the Meno-D, built specifically to catch perimenopausal depression, and Australian clinical guidance now urges family doctors to raise mental health proactively at this stage rather than wait for women to bring it up. There is no good reason that cannot become the standard everywhere.

You can strengthen your own case. Track your symptoms over a few weeks, note how they connect to your sleep and your cycle, and bring that record to your appointment. Name plainly what you are experiencing, and ask directly about the options in this article. If you are not taken seriously, you are well within your rights to request a referral or a second opinion. This is a medical issue with medical solutions, and you are allowed to insist on both.

Perimenopause really can affect your mental health, and that is not a sign of weakness or a flaw in your character. It is a recognized, well-studied feature of a major hormonal transition. The mood changes are real, the biology behind them is real, and the risk is real, especially if you have faced depression or anxiety before. But the help is just as real. If you take nothing else from this, take this: what you are feeling has a name, it has causes, and it has treatments. You do not have to white-knuckle your way through it, and you do not have to do it alone.

The key sources behind this article, for anyone who wants to read further:

• Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause, 2018 (NAMS and the National Network of Depression Centers).
• Society of Obstetricians and Gynaecologists of Canada. Menopause Hub.
• Bromberger JT, et al. Does risk for anxiety increase during the menopausal transition? Study of Women’s Health Across the Nation (SWAN), on anxiety across the menopause transition, 2013.
• Schmidt PJ, et al. Effects of estradiol withdrawal on mood in women with past perimenopausal depression: A Randomized Clinical Trial. JAMA Psychiatry, 2015 (National Institute of Mental Health).
• Gordon JL, et al. Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition. JAMA Psychiatry, 2018.
• American College of Obstetricians and Gynecologists. Mood changes during perimenopause are real.
• Johns Hopkins Medicine. Perimenopause and anxiety.
• Centre for Addiction and Mental Health (Meyer JH, Rekkas PV, et al.). Brain protein may explain depression in pre-menopausal women. JAMA Psychiatry, 2014.
• Hendriks O, et al. Menopause and suicide: a systematic review, 2025.
• Hendriks O, et al. Prevalence of Low Mood, Thoughts of Self-Harm and Suicidal Ideation in Women Affected by the Perimenopause and Menopause. BJPsych Open, 2024.
• CMAJ. A pragmatic approach to the management of menopause, 2023.
• Jean Hailes for Women’s Health (Kulkarni J, Baber R). Top five GP questions on menopause and mental health, 2023.

This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider for personal medical guidance.